REPLIGEN CORP — Director's Dealing 2020

Dec 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-12-16

Reporting Person: KURIYEL RALF (Senior VP, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-16	Common Stock	S	435	$186.18	Disposed	25654	Direct

Footnotes

F1: Sale of shares in the open market to cover tax liability resulting from the release of restricted stock units.